Formualtion and Administration Flashcards

1
Q

what should happen when a patient has difficulty swallowing and is unlikely to cope with tablets and capsules

A
  • all medicines should be reviewed
  • appropriate formulation changes

decide whether each one can be:

  1. safely manipulated to aid administration
  2. discontinued
  3. temporarily withheld
  4. switched to an alternative medicine in the same class
  5. switched to an alternative formulation or route
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

why is it not appropriate to crush all types of medication

A
  • increases the risk of adverse effect

- reduce therapeutic effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Name some examples of medications that you should not crush

A
  • modified release tablets or capsules
  • any medication that can cause irritation to the stomach.
  • some tablets are meant for slow release so by crushing them this can cause side effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the different forms of medicine that can be administered via the parenteral route

A
  • solution for IV injection
  • solution for IM injection
  • solution for intrathecal injection
  • solution for subcutaneous injection
  • subcutaneous implant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How many different forms of medication can be administered via the enteral route

A
  • Enema
  • Capsule
  • coated tablet
  • effervescent tablet
  • modified release tablet
  • oral solution
  • oral syrup
  • oral suspensions
  • rectal suppository
  • soluble tablet
  • tablet
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the most appropriate way to give a medicine to a young child

A
  • small volume liquid medicines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what factors do you consider when choosing an appropriate formulation for a child

A
  • age and developmental stage of the child
  • acceptability and palatability
  • frequency of dosing
  • easy of administration
  • convenient and reliable administration
  • impact on lifestyle
  • minimum exposure to excipients
  • whether the formulation can deliver doses variable to age/weight/BSA
  • route of administration needs to be acceptable to the child and their parents/carers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are excipients

A
  • these are usually pharmacologically inactive substances that are added to formulations to improve or alter the acceptability, shelf-life, stability or carry the active ingredient
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

who should avoid aspartame

A
  • it is a source of phenylalanine that should be avoided in patients with pheynketonuria this is a genetic disorder the prevents the breakdown of phenylalanine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

who should Arachis oil be avoided in

A
  • this should be avoided in peanuts allergic patients

- it is used as an excipient to dissolve the active drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

why should you avoid large doses of syrups

A

syrups can be sucrose base or contain sorbitol

- Sorbitol can cause diarrhoea in large doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the 4 stages of pharmacokinetics

A
  • absorption
  • distribution
  • metabolism
  • excretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what can interpreting pharmacokinetic information also tell us

A
  • how water or lipid soluble a drug is

- how the drug is cleared from the body (and hence if you need to be concerned about kidney or liver impairment)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

in order for most drugs to work unless for a topical effect they need to be…

A

absorbed into the blood stream

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

where does most drug absorption occur

A
  • most drug absorption occurs in the small intestine and not in the stomach
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

name factors that affect the process of oral absorption

A
  • chelation
  • solid or solution
  • modified-release preparations
  • enteric coating
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what is chelation

A

this is when drugs can be bound to some electrolytes, particularly divalent ions such calcium and iron that will stop absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Give some examples of drugs that are affected by chelation

A
  • tetracycline antimicrobials and calcium
  • tetracycline antimicrobials and antacids
  • tetracycline antimicrobials and iron preparations
  • ## quinolone antimicrobials and iron preparations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How long after taking colestryamine should drugs be taken

A
  • binds to other medicines

- other drugs should be given either 1 hour before or 4-6 hours after colestyramine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

if the drug is given as a solution…

A

absorption is faster - this isn’t always true - weak acidic drugs such as aspirin may precipitate out in the acidic environment of the stomach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what are modified released preparations

A
  • these are specifically formulated to release over a period of time
  • not always appropriate for patients who have had bowel resection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is enteric coating

A
  • this technology protects the drug for the acidic environment of the stomach and can protect the stomach from the drug
  • means that the drug will bypass the stomach and enter the small intestine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what problem can an IM injection have in terms of absorption

A
  • poor blood flow will slow the rate of drug absorption

- a very well perfused muscle will have a rapid drug absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What other routes of administration depend on absorption through a mucus membrane

A
  • rectal
  • nasal
  • sublingual

Rate will depend on blood flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What can affect absorption through the skin

A
  • having a hot bath - increases blood flow to the skin - led to fatalities in patients using fentanyl patches
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is bioavailability

A
  • this is the proportion of the medicine that finally makes the systemic circulation where it is available to act at the effector site
27
Q

what way of administering the drug has 100% bioavailability

A

IV drug

28
Q

what can affect bioavailability of a drug

A
  • route that it is administered
29
Q

name drugs whereby there is variation in bioavailability due to the route of administration

A
  • ciprofloxacin
  • digoxin
  • morphine
30
Q

name some examples when a patient wouldn’t be able to take an oral medication

A
  • nausea and vomiting

- dysphagia

31
Q

Name some examples of things that effect IM absorption

A
  • morbid obesity

- muscle wasting

32
Q

What does half life dictate

A
  • frequency of administration

- how long it takes for the drug to be eliminated from the body

33
Q

in what patients do you need to extend the half life

A
  • in patients with renal failure
34
Q

how can you slow down the breakdown of the preparation in modified release preparations

A
  • mixing the drug in a waxy base so that the drug leaches out
  • coating beads of the drug and either compressing them together or filling a capsule with them
35
Q

Name drugs that should be prescribed by brand rather than generically

A
  • dilitazem preparations
  • sone anti-epileptics
  • lithium salts
  • theophylline preparations
  • some immunosuppressant therapies (e.g. tacrolimus)
36
Q

why do some drugs need to be prescribed by brand name rather than generically

A
  • can be a problem with modified release preparations being different
  • all drugs have to be bioequvilance but this is not the same as therapeutic equivalence which can be a problem with drugs that have a narrow therapeutic index
37
Q

oral ciprofloxacin should be…

A

taken at a different time to indigestion remedies

38
Q

What are biological medicines

A
  • those with active ingredients derived from a living source
39
Q

what is prescribing biological medicines subjected to

A
  • prescribing biological medicines is often subject to guidelines from NICE and NHS England since the majority of these therapies have a high associated cost
40
Q

What has biological medicines led to

A
  • the development of biosimilar formulations that re likely to be significantly cheaper than biological medicines
41
Q

What is a biosimilar medicine

A
  • this is a biological medicine that is highly similar and therapeutically equivalent to the reference biological medicine
42
Q

what is the difference between biosimilar and generic medicines

A

generic medicine are not the same as biosimilar medicines

- a generic medicine will be identical in terms of the active ingredient to its reference medicine

43
Q

What is a marketing authorisation for

A
  • necessary before a medicine can be marketed for sale or supply
44
Q

What is off label

A
  • refers to medicines used outside the conditions of their marketing authorisation
45
Q

What are unlicensed preparations

A

this is when there is a need to use a medicine that doesn’t have a product authorisation in the UK

46
Q

What are the three categories of unlicensed preparations

A
  1. the medicine is produced and licensed in another country and imported
  2. the medicine is unlicensed and produced in a licensed manufacturing unit in this country
  3. the medicine is unlicensed and produced in an unlicensed manufacturing facility such as a pharmacy department
47
Q

What is a special

A
  • a special is an unlicensed preparation of a medicine
48
Q

Give examples of specials

A
  • specials are liquids or powder versions of a solid oral dosage form, specifically intended for patients who have swallowing difficulties
49
Q

What patient factors should you consider when you prescribe a medicine that is supplied as a special

A
  • consider the excipients - many medicines are quite unpleasant to taste and digging the taste can entail the use of strong flavours
  • monitor the patient and not change in clinical status
50
Q

What other factors should you consider when prescribing a medicine that is a special

A
  • as specials are unlicensed the responsibility for their use rests with you as the prescriber
  • be aware of your trusts policy for use and documentation
  • ensure a seamless transition between care settings
  • cost
51
Q

why would you not crush a tablet In a tube fed patient

A
  • can lead to blockage of the tube
52
Q

Why is the timing of the dose important

A
  • avoid adverse effects

- optimise therapeutic effect

53
Q

when should statins be administered

A

at night

54
Q

name some medicines that should be prescribed and administered at specific times

A
  • antimicrobials
  • insulin
  • nitrates
  • medicines used in Parkinsons Disease
  • modified released morphine sulfate
  • timolol eye drops
55
Q

why should there be a nitrate free period

A
  • there should be a nitrate free period of at least 8 hours to prevent the patient from developing a tolerance to the medicine
56
Q

How do you give medicines in enteral feeding

A
  • stopping the feed briefly
  • flushing the tube
  • administering the medicine
  • flushing the tube again and restarting the feed
57
Q

what do you do if the feed reduces the absorption of the medicine in enteral feeding

A
  • stop the feed for two hours to allow it to leave the stomach
  • give the required dose
  • restart the feed two hours later
58
Q

if you expect the patient to take the correct medication at the correct time then what do you need to ensure

A
  • a shared decision between you and the patient and the patient has consented to treatment
  • the most effective treatment for the condition
  • in a formulation that the patient is able to take
  • in a formulation that is acceptable to the patient
59
Q

what information must you give before you prescribe

A
  • adverse effects
  • administration
  • alternative treatments
  • effectiveness
  • expected duration of treatment
  • formulation
60
Q

What factors prevent your patient from providing informed consent

A
  • cultural differences
  • difficulty reading
  • health problems
  • lack of capacity to make this type of decision
  • language barriers
  • mental health problems
61
Q

What are the basic principles of the mental capacity act

A
  • a person is assumed to have capacity unless it is established otherwise
  • everyone must be helped to understand and make decisions
  • an unwise decision doesn’t mean a person is incapable
  • if someone lacks capacity you must act in their best interests
  • is there an equally effective, but less restrictive alternative
62
Q

How do you test capacity

A
  • does the patient have a condition which impairs their ability to make decisions
  • does this impairment mean that they are unable to make a specific decision when required
63
Q

How do you know if a person can make a specific decision

A
  • understand information about the decision to be made
  • be able to retain that information
  • be able to use that information to make their decision
  • be able to communicate that decision back to you